Cleared Special

K120888 - PSG-1100 SLEEP DIAGNOSTIC SYSTEM (FDA 510(k) Clearance)

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K120888 · Nihon Kohden Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
231d
Days
Class 2
Risk

K120888 is an FDA 510(k) clearance for the PSG-1100 SLEEP DIAGNOSTIC SYSTEM. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Nihon Kohden Corp. (Foothill, US). The FDA issued a Cleared decision on November 9, 2012 after a review of 231 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Nihon Kohden Corp. devices

Submission Details

510(k) Number K120888 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2012
Decision Date November 09, 2012
Days to Decision 231 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
83d slower than avg
Panel avg: 148d · This submission: 231d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 187
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K120888.
New Wave System
K260455 · Zeto, Inc. · Mar 2026
Flexset System
K233403 · Zeto, Inc. · Apr 2024
Neuronaute Plus
K231366 · Bioserenity Sas · Nov 2023
Q21
K221959 · Neurofield, Inc. · Aug 2023
SPARK Scan
K231457 · Spark Neuro, Inc. · Aug 2023
Cumulus Functional Neurophysiology Platform
K221963 · Cumulus Neuroscience Limited · Apr 2023